Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
Associated filings
- 14 Jul 23 EFFECT Notice of effectiveness
- 13 Jul 23 424B3 Prospectus supplement
- 11 Jul 23 S-4/A Registration of securities issued in business combination transactions (amended)
-
22 Jun 23 S-4/A Registration of securities issued in business combination transactions (amended)
- 10 May 23 S-4 Registration of securities issued in business combination transactions
CRVO similar filings
Filing view
External links
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
We consent to the use of our report dated March 24, 2023, with respect to the consolidated financial statements of Diffusion Pharmaceuticals Inc., included herein, and to the reference to our firm under the heading “Experts” in the prospectus.
/s/ KPMG LLP
McLean, VA
June 20, 2023